These interactions were enriched in growth factor- and cytokine-mediated pathways, including TGFB1-TGFBR2, IL6-IL6R, and EGF-EGFR signaling, suggesting that AP1AR upregulation amplifies paracrine networks supporting tumor proliferation and immune remodeling. The gene discussed is EGF; the disease is neoplasm.